Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway

Latest Issue

Acta Pharmacologica Sinica is a Transformative Journal; authors can publish using the traditional publishing route OR Open Access.
Our Open Access option complies with funder and institutional requirements.

Browse Articles

Focus

40 years of APS

We celebrate the 40th anniversary of Acta Pharmacologica Sinica (APS) with a series of specially commissioned Reviews and Articles across the diverse areas of the journal’s scope, highlighting the advances made in pharmacological research.

Nature events Directory

  • This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

    Committee on Publication Ethics